Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
It supports collagen production, aids digestion, promotes better sleep, and helps stabilize blood sugar
New Obesity Drugs: Why Wave-007 Is Stealing the Spotlight Episode Timeline & Main Topics 00:00 Opening & Community Update First week doing the podcast fully live thanks to the On The Pen community Overview of why this weeks news is a major turning point in obesity medicine 02:30 Introducing the One-and-Done Obesity Drug (Wave Life Sciences) WVE-007 early data drops Why this therapy is unlike GLP-1s or any nutrient-stimulated hormone Fat loss results and lean-mass increase 06:30 How Wave-007 Works: INHBE Gene Silencing Mechanism behind visceral fat reduction Why this shifts the field toward quality of weight loss 09:15 Why Lean-Mass Preservation Matters Current GLP-1 medications and muscle loss Why women dominate trial enrollment and the larger implications Medicare patients and the coming wave of GLP-1 coverage 13:45 The Future of Maintenance Therapies Fractyl Health Revita results Lillys orforglipron maintenance design Why holding the line after GLP-1 therapy is the next major category 17:30 Amylin Agonists: Cagrelintide vs
Melatonin inhibits autophagy and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis
Appointments also provide accountability and education, giving patients clarity around nutrition, hydration, and lifestyle habits that support long-term results
Fast Delivery Discreet Packaging 24 Hours online support Additional Information Payment Terms T/T, Western Union Port of DispatchIndia Delivery Time7 Interested in this product
